Table 3

MCV, HbF, D50, and %DRBCs by α-thalassemia status

α-thalassemia statusNo.MCV, mean ± SDHbF, mean ± SDD50, mean ± SD%DRBCs, mean ± SD
Normal 216 92.6 ± 8.6*† 8.4 ± 5.7* 1.096 ± 0.003* 14.6 ± 7.7* 
1-gene deletion 183 84.6 ± 6.8*‡ 6.8 ± 4.7* 1.095 ± 0.003* 12.5 ± 7.3* 
2-gene deletions 46 71.1 ± 4.4†‡ 4.4 ± 3.7* 1.092 ± 0.003*† 4.5 ± 4.3*† 
Gene triplication 92.4 ± 7.9‡ 7.8 ± 4.8 1.098 ± 0.002† 16.9 ± 4.8† 
α-thalassemia statusNo.MCV, mean ± SDHbF, mean ± SDD50, mean ± SD%DRBCs, mean ± SD
Normal 216 92.6 ± 8.6*† 8.4 ± 5.7* 1.096 ± 0.003* 14.6 ± 7.7* 
1-gene deletion 183 84.6 ± 6.8*‡ 6.8 ± 4.7* 1.095 ± 0.003* 12.5 ± 7.3* 
2-gene deletions 46 71.1 ± 4.4†‡ 4.4 ± 3.7* 1.092 ± 0.003*† 4.5 ± 4.3*† 
Gene triplication 92.4 ± 7.9‡ 7.8 ± 4.8 1.098 ± 0.002† 16.9 ± 4.8† 

The symbols indicate significant differences between the means sharing the same symbol. For example, the mean MCV for SS patients with normal α-thalassemia status differed significantly from that of patients with 1- or 2-gene deletions. The statistical significance, defined as P < .05, was pairwise comparisons using the Tukey adjustment.

Close Modal

or Create an Account

Close Modal
Close Modal